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Apslipuprauln E- (ApoE-) rich high-density IipeproIcin (MDL), which WI preprrrd from rhc bound fracricm al’nunnalipcmic valun~ecrx an hepa- 
rin&phuroae and from I hyprrlphrrlipclpreleincmic pn\icnt, peknrly inhibited ngyrcyatian of humnn pla~rlc~x In II, dose-dcpcndcnt rashinn. Di- 
myristoyl pkosplratidylcholinc lipusamr with epnE (apeEs DMPC) also inhibited plattlet aggrrgutiun, und incubation of washed phtclr~r with 
opoE* DMPC resulted in the relcn~c of cholesterol into the ruprnatant in II time* and dare-deprndcm mnnncr, Thrsc rcruhr xulg~cs( rhnt up& 
plny?l a major ralc in the inhibirary eiket of ~qx.&rich HBL in plrrrelct function, presumably due to the rclc~txr UF chnleatcrul from tha ph~smu 
mcmbranc. 
High-dcnrhy lipoprotein; Chelcalcrel; fWclcr qgrcgtlrion; Apulipoprolcin E 
1. INTRODUCTION 
Platelets play an important role in the formation of 
thrornbus and atherosclerotic lesions [11. Platelets from 
the patients withhypercholesterolemia show an increase 
in aggrcgability, especially for eoinephrine [2,3] and 
their plasma membranes contain a great deal of choles- 
terol, suggesting that the content of cholesterol in the 
plasma memhranc has a critical role in determining the 
sensitivity to stimuli. A number of reports have in- 
dicated that low-density lipoprotein (LDL) enhances 
agonist-induced platelet aggregation, whereas high- 
density lipoprotein (HDL) has an opposite effect [4-91. 
Recently, Desai et al. [g] showed that one of the critical 
factors of HDL in reducing the aggregability was the 
content of apoE, because HDLz showed more potent 
inhibition than HDLs. However, the mechanism of po- 
tent inhibition by apoE-rich HDL remains unknown. 
In this report, we focus on the role of apoE in the in- 
hibitory effects of apoE-rich HDL on platelet function 
and investigate the interaction of dimyristoyl phospha- 
tidylcholine liposome with apoE (apoE*DMPC) with 
platelets, especially in terms of cholesterol exchange in 
the plasma membrane. 
2. MATERIALS AND METHODS 
2. I, Materials and proteins 
Dimyristoyl phosphatidylcholinc (DMPC) and luciferine-luciferase 
were purchased from Sigma (St. Louis, MO). cu-thrombin was pur- 
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chased from Mochida Phsrmnccurical (Tokyo, hpan), Nn’“‘l was 
obtained from New England Nuclear (Bamn, MA), Rcrombinant 
apoE was a gift from Mitsubishi Karei (Kanagawa, Japan). Apolipo- 
protein A.1 (ApoA-I) was purified from normal plasma according to 
the method of Schonfcld CI al. [91. 1,3,3,4-telrachloro-3~~-di- 
phenylglycouril (IODO-GEN) was purchased from Pierce (Rockford, 
IL). Hcparin-Scphnrosc was made according to the method of Iveriur 
ct al, [IO]. ConAGphnrosc was purchased from Pharmacia, 
Uppsnla, Sweden. 
2.2. Isolation of pktsrnn lipoprofeins 
Human HDL (c-f= 1.063-I .21 g/ml) was isolated from plasma ob- 
tained from normolipemic fasted volunteers by ultracentrifugntion in 
a 50 Ti rotor (Hitachi) (71. ApoE-rich and apoE-poor HDL fractions 
of normal plasma were prepared by heparinSepharore column 
chromatography as described by Wcisgraber ct al. [l I], The ApoEi 
ApoA-1 ratio in apoE-rich HDL fraction was calculated to bc about 
0.65. 
The ApoE-rich HDL fraction was also isolated from plasma of a 
hyperalphalipoproteinclnic patient with cholesteryl ester transfer pro- 
tein deficiency. A fraction of d< 1,063 g/ml of the patient’s plasma 
was applied to the ConA-Sepharose column to remove apoB as 
described previously [l2), and flow-through fractions (apoE-rich 
HDL) were collected. The ApoE/ApoA-I ratio of this fraction was 
about 0.9. 
The ApoE’ DMPC complex or apoA-1’ DMPC complex was 
prepared by incubating DMPC with recombinant apoE or purified 
apoA-I overnight at room temperature with a lipoprotein/DMPC 
ratio of 1:3.75 (weight/weight) according to the method of Innerarity 
et al. [13]. Free apolipoprotein was removed by ultracentrifugation , 
The electron micrography of negatively stained apoE* DMPC was 
carried out according to the tnethod of Basu et al. [14]. 
2,3, Iodination and binding experiments 
LDL was iodinated by using IODO-GEN [15]. The specific ac. 
tivities were 200-400 cpm/ng protein. [‘251]LDL binding was carried 
out at 37QC as described previously [7]. 
2.4. Plrrteiet function 
Washed platelets were prepared as described previously [16]. 
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3. RESULTS AND DISCU%SIBN 
We rcportcd prcviousiy (71 that HDLa inhibited 
collagen- and thrombin-induced platelet algregarion 
mom potenrly than HDLI\, Phesc results confirm the 
earlier results of Bcsai ct al. [S], who suggested that the 
more potent inhibition of ADP-induced aggregation by 
HDLz than that by HDL3 was derived from the dif- 
ference in apoE conrcnr. 
CapaE/q~erA-f = 6.9) fran a I~yperalphalipopro~eIne- 
mie patient with plasma cholerteryl ester transfer pro- 
tein deficiency on platelet qg,regation. This fraction 
also inhibited collagen- and thrombin-induced platelet 
aggregation i  a do&-dependcnr fashion (Fig 2). HDL 
from normal donors at concentrations up to 0.2 mg 
protein/ml showed little inhibition (data kot shown), 
These results uglcst that apoE may have a criricsll role 
in the potent inhibition of platelet function by HDLa, as 
suggested by Desai et al, [8I. 
ApoE4ch HDL (apoE/apoA-I = 0.65) from normal 
donors prepared by heparin-Sepharose column chroma- 
In order to study the inhibitory effect of apoE on 
apsISrich HDL which also conrains other apolipopran 
tcins, i.e. apoA-I, we prepared liposomes consisting of 
only apoE and DMPC, which had disc forms like nas- 
cent HDL (Fig 3A). ApoE’ DMPC inhibited collagen- 
Fig, i. inhibition of piatekt aggregation and ATP release by apoE-rich !-!DL. (A) Elution profile of heparin-Sepharose column. The concentration 
of protein in each fraction was measured by the method of Bradford [30]. (B,C,D) Inhibition of ADP- (B), collagen-(C), or thrombin- (D) induced 
platelet aggregation and ATP release by apoE-rich HDL. The values in parentheses are those of ATP released (uM). Agonists were added to washed 
platelets (30% lO’/,ul) preincubated with several protein concentrations of apoE-rich HDL (shown in figures) for 30 min at 37°C. LTU, light 
transmission unit. 
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Fig. 3. Inhibition of [1251]LDL binding to platelets and platelet aggregation by apoE*DMPC. (A) Electron micrography of negatively stained 
apoE*DMPC. (B) Inhibition of [‘*511LDL binding by cold LDL (a), apoE*DMPC (8) or apoE alone (A), (C,D) Inhibition of collagen- (C); or 
thrombin- (D) induced platelet aggregation by several protein concentrations of HDL, (a) control; (b) apoA-l.DMPC, 100 &ml; (c,d,e) 
apoE* DMPC, 25 /rg/ml, 1OOyg:/ml and 200pg/ml, respectively. Experimental conditions were the same as in Fig. 1, LTU, light transmission unit. 
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wnd thrombin-jl~~ueed pIatelcr ~~~r~~~tion ii  Al dole- 
dependent fashion {Fig, 367,D). fn contrast, few ina 
hlbirory cffeeca were seen with apoA-I- BMPC UF to 0, I 
m&/n& ApoE-DMBC gorenrly inhibited [I* I]LJX. 
binding to plrfelefa CR& X4). Scrrrehrrd Rnalysio reveal* 
cd ohnf the affinify was about 18 rknes that of native 
LDL (unpublished observation). Neither DMPC (data 
not shown) nor apoE alone (Fig 38) showed any inhibi- 
tion, ~u~~~~~~~$ that apoE acquires the heility of in- 
hibition by forming an a&e eomplcx with DMPC, 
Thus, platelct=typc LDL receptor [7,20] may nhare the 
cnpaeity of bindin to both apoF3 and apoE, like the 
elaxsieal LBL recepfor of fibroblarts [2L]. 
Fig, 4. Inhibition ol thronrbin-induced pla~clct ag~rc@cien and the 
inerrase in [CO’“)~ by npoE* i&WC. Washed platelet (30 x lO’/pl) 
were pfcincubrued nt 37% in the presence or ubacnec of apoE~ BMPC 
(I00 &nrl) for various incubntion periods, and ~Rcn thrombin (0, I 
U/ml) was added. The extent of [Caa“]i ircrcase (0,01 and maximal 
slope (aggregation/min) (A, A) were calculs&d as pcrccnt of control. 
The vnlrres are means f SD. of 3 cxpcrirnents. apoA-I*DMPC 
(0, A); apuE*DMPC (0, A). 
Why does apoE~ BMPC have inhibitory peopcrties? 
To obtain insight into ttw mechanism of this inhibition, 
the effects of apoEm DMPC on [Ce”“]i increase and ag- 
gregacion by rhrombin (0.1 U/ml) were examined for 
various incubation times. Borh the increase in [Ca’*]I 
and the ageregntion were inhibired by apoE#DMPC 
ClOO&ml) in a rime-dependent fashion (Fig 4), No in- 
hibition was seen wifh a shorter incubation time, i.e. 5 
min (Fig. 4). Thus apoE*DMPC seetns to inhibit the 
thrombin-induced receptor-mediated signal transduc- 
tion, by affecting the plasma membrane in a rime- 
dependent fashion. 
We measured the amount of cholesterol in the super- 
natant during incubation of washed platelets with 
apoE* DMPC. ApoE*DMIJC released the cholesterol in 
the supernatant in a dose- and time-dependent fashion 
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Fig. 5. The release of cholesterol from platelet membrane by apoE+ DMPC. A. Cholesterol or LDH release as  function of lipoproteins of DMPC 
alone. Washed platelets (30 x lo’/& were preincubated with apoE* DMPC, Apbh-i*DkiPC or DMPC alone for 30 min al 37°C and then put on 
ice. The supernatant after centrifugation at 3000 rpm for 10 min was determined for cholesterol content or LDH release. Cholesterol release 
(0, A, 0); LDH release (e, A ,m); apoE.DMPC (0,8); apoA-l.DMPC (A, A); DMPC alone (0,~). The concentration of DMPC vesicles, 360 
&ml, was the same concentration of DMPC that was present in the lOOpg/ml apoE*DMPC. B. Cholesterol or LDH release by apoE*DMPC 
(100 &ml) as a function of incubation time. Experimental conditions are the same as in A. 
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(Pips. SA,B), ApoE* IXWC: WI fi@ml) ~cleasccf 
1Qa3% of ekslkatcroI Pbr 30 nin of incubrfIon 
(meank$D for J separafc cxpcrimenfs), tiftje cPfcef 
wtu seen with &her BMPC ~Isna m agoA- 1 Bh4BC. 
LDH release was leas than 3% in (111 samples (Fig. fA), 
The time dependency of the extent ofcholercerol relers= 
ed by apoE 0 DMPC was parallel with chat of the inhibiw 
tion of the hCaf*]l increase and the aggregation induced 
by chrombin (Figo 4 and 33). A longer ineubarian with 
apoE’DMPC:(lQB/cg/ml), for 6 h, caused the apparent 
release of lSDH (Fig, SB), suggesting that removal of 
cholesterol From the plasma membrane l nds fa fragility 
of platelet membrane. 
In 1975 Shartil et al. [22) showed that platelets in- 
cubated with cholesterol-rich liposomes [high eholes- 
terol to phosphalipid ratio (C/PL)] had an increased 
sensitivity to epinephrine and ABP and that their 
platelets contain higher amounts of’ cholesterol, 
Platelets exposed to cholesterol-rich liposomes were 
found to have increased membrane microviscosity [23) 
and increased basal levels of adenylate cyclase [24], 
These observations in vitro may have a counterpart in 
human disease since plarclets from individuals with type 
ila hyperlipoproteinemia h ve an increase in membrane 
C/PC [25], and they are more sensitive than normal to 
aggregating agents [2,3]. More recent studies have in- 
dicated that platelets with decreased C/PL showed a 
decrease in the liberation of arachidonafe [26,27], the 
binding capacities of fhrombin [28] and the levels of 
fhromboxane RX formation [27,29]. Thus, the 
cholesterol content of the plasma membrane has been 
thought to have a crucial role in determining the sen- 
sitivities to agonists. 
This is the first report showing that DMPC liposomes 
with apoE release cholesterol from the platelet mem- 
brane, We here propose a hypothetical model: that 
apoE-rich HDL releases cholesterol from the plasma 
membrane of platelets, resulting in a decreased 
response to stimuli. However, since apoE*DMBC is a 
simple model for apoE-rich WDL and lacks other 
apolipoproteins, i.e. apoA-I as well as lipids like 
cholesterol and triglyceride, we cannot exclude the 
possibility that other inhibitory factors may lead to per- 
turbation of the lipid-protein interaction in platelet 
membranes with different mechanisms, resulting in a 
decreased platelet function. 
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